Which has grown faster, IBRX or UHS?

Over the past five years, IBRX grew revenue faster — IBRX at a 202.97% CAGR versus UHS at 8.21%.

Does IBRX or UHS pay a bigger dividend?

UHS pays a dividend (0.45% yield), while IBRX has no payments in the available dividend history.

Is IBRX or UHS more profitable?

UHS runs the higher net margin — IBRX at -598.56% versus UHS at 8.42%.

How have IBRX and UHS total returns compared?

Over the past 10 years, IBRX delivered 2.95% and UHS delivered 4.35% annualized total return. Past performance doesn't predict future results.

ImmunityBio, Inc. (IBRX) vs Universal Health Services, Inc. (UHS)

A side-by-side comparison of ImmunityBio, Inc. and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IBRX

ImmunityBio, Inc.

$10.49B

$10.02HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

UHS

Universal Health Services, Inc.

$10.76B

$177.74HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — IBRX vs UHS

growth of $100 · dividends reinvested · last 10y

IBRX +41.8% (+3.6%/yr)UHS +50.5% (+4.2%/yr)UHS compounded faster over this window

IBRX UHS

IBRX vs UHS: by the numbers

•UHS is the larger company ($10.76B vs $10.49B market cap).
•UHS is profitable (8.42% net margin) while IBRX runs a net loss (-598.56%).
•IBRX grew revenue faster over the past five years (202.97% vs 8.21% CAGR).
•UHS pays a dividend (0.45% yield), while IBRX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	IBRX	UHS
P/E ratio	N/A	7.29
Forward P/E	N/A	7.87
PEG ratio	N/A	0.46
P/S ratio	63.27	0.59
P/B ratio	N/A	1.43
EV / EBITDA	N/A	5.88
FCF yield	N/A	7.68%

Profitability

Metric	IBRX	UHS
Gross margin	94.63%	90.69%
Operating margin	-226.00%	11.36%
Net margin	-598.56%	8.42%
ROE	N/A	20.31%
ROIC	-45.63%	11.74%

Dividends

Metric	IBRX	UHS
Dividend yield	N/A	0.45%
Payout ratio	N/A	3.28%

Growth (annualized)

Metric	IBRX	UHS
Revenue CAGR (5Y)	202.97%	8.21%
EPS CAGR (5Y)	N/A	16.19%
FCF CAGR (5Y)	N/A	-12.18%
Total return CAGR (5Y)	0.39%	6.18%

Frequently asked

Which has grown faster, IBRX or UHS?: Over the past five years, IBRX grew revenue faster — IBRX at a 202.97% CAGR versus UHS at 8.21%.
Does IBRX or UHS pay a bigger dividend?: UHS pays a dividend (0.45% yield), while IBRX has no payments in the available dividend history.
Is IBRX or UHS more profitable?: UHS runs the higher net margin — IBRX at -598.56% versus UHS at 8.42%.
How have IBRX and UHS total returns compared?: Over the past 10 years, IBRX delivered 2.95% and UHS delivered 4.35% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IBRX analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

Universal Health Services P/E ratio Universal Health Services dividend yield ImmunityBio ROE Universal Health Services ROE ImmunityBio operating margin Universal Health Services operating margin ImmunityBio revenue growth Universal Health Services revenue growth ImmunityBio free cash flow Universal Health Services free cash flow

ImmunityBio & Universal Health Services appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.